Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Ecstasy and Agony of Assay Interference Compounds
Courtney C. Aldrich, Carolyn R. Bertozzi, Gunda I. Georg, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 6, pp. 2165-2168
Open Access | Times Cited: 152

Showing 1-25 of 152 citing articles:

The Therapeutic Potential of Naringenin: A Review of Clinical Trials
Bahare Salehi, Patrick Valère Tsouh Fokou, Mehdi Sharifi‐Rad, et al.
Pharmaceuticals (2019) Vol. 12, Iss. 1, pp. 11-11
Open Access | Times Cited: 644
The Light and Dark Sides of Virtual Screening: What Is There to Know?
Aleix Gimeno, María José Ojeda, Sarah Tomas‐Hernández, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 6, pp. 1375-1375
Open Access | Times Cited: 217
Activation of Nrf2 signaling by natural products-can it alleviate diabetes?
Manuel Matzinger, Katrin Fischhuber, Elke H. Heiß
Biotechnology Advances (2017) Vol. 36, Iss. 6, pp. 1738-1767
Open Access | Times Cited: 188
Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein–Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2
Damir Bojadzic, Óscar Garnica, Jinshui Chen, et al.
ACS Infectious Diseases (2021) Vol. 7, Iss. 6, pp. 1519-1534
Open Access | Times Cited: 122
Discovery of baicalin and baicalein as novel, natural product inhibitors of SARS-CoV-2 3CL proteasein vitro
Haixia Su, Sheng Yao, Wenfeng Zhao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Closed Access | Times Cited: 133
Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
S. C. Verma, Danielle Twilley, Tenille Esmear, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 130
Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors
Annachiara Gandini, Manuela Bartolini, Daniele Tedesco, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 17, pp. 7640-7656
Open Access | Times Cited: 98
Colloidal aggregation: From screening nuisance to formulation nuance
Ahil N. Ganesh, Eric N. Donders, Brian K. Shoichet, et al.
Nano Today (2018) Vol. 19, pp. 188-200
Open Access | Times Cited: 91
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase
Jingkun Zeng, Florian Weissmann, Agustina P. Bertolin, et al.
Biochemical Journal (2021) Vol. 478, Iss. 13, pp. 2405-2423
Open Access | Times Cited: 63
The Chemical Probes Portal: an expert review-based public resource to empower chemical probe assessment, selection and use
Albert A. Antolín, Domenico Sanfelice, Alisa Crisp, et al.
Nucleic Acids Research (2022) Vol. 51, Iss. D1, pp. D1492-D1502
Open Access | Times Cited: 42
High-Throughput Screening for the Discovery of Enzyme Inhibitors
Matthew D. Lloyd
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 19, pp. 10742-10772
Open Access | Times Cited: 66
An appraisal of natural products active against parasitic nematodes of animals
José Garcia-Bustos, Brad E. Sleebs, Robin B. Gasser
Parasites & Vectors (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 64
Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1)
Huan‐Chieh Chien, Claire Colas, Karissa Finke, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 16, pp. 7358-7373
Open Access | Times Cited: 61
Nuisance compounds in cellular assays
Jayme L. Dahlin, Douglas S. Auld, Ina Rothenaigner, et al.
Cell chemical biology (2021) Vol. 28, Iss. 3, pp. 356-370
Open Access | Times Cited: 49
Probing Fluorinated Motifs onto Dual AChE-MAO B Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Early-ADME Studies
Mariagrazia Rullo, Marco Cipolloni, Marco Catto, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 5, pp. 3962-3977
Closed Access | Times Cited: 31
Inhibitors of LexA Autoproteolysis and the Bacterial SOS Response Discovered by an Academic–Industry Partnership
Charlie Y. Mo, Matthew J. Culyba, Trevor Selwood, et al.
ACS Infectious Diseases (2017) Vol. 4, Iss. 3, pp. 349-359
Open Access | Times Cited: 55
GAIN domain–mediated cleavage is required for activation of G protein–coupled receptor 56 (GPR56) by its natural ligands and a small-molecule agonist
Beika Zhu, Rong Luo, Peng Jin, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 50, pp. 19246-19254
Open Access | Times Cited: 53
Predicted Biological Activity of Purchasable Chemical Space
John J. Irwin, Garrett Gaskins, Teague Sterling, et al.
Journal of Chemical Information and Modeling (2017) Vol. 58, Iss. 1, pp. 148-164
Open Access | Times Cited: 52
Quantifying the Interactions between Biomolecules: Guidelines for Assay Design and Data Analysis
Peter J. Tonge
ACS Infectious Diseases (2019) Vol. 5, Iss. 6, pp. 796-808
Open Access | Times Cited: 52
Design, synthesis and biochemical evaluation of novel multi-target inhibitors as potential anti-Parkinson agents
Simone Carradori, Francesco Ortuso, Anél Petzer, et al.
European Journal of Medicinal Chemistry (2017) Vol. 143, pp. 1543-1552
Closed Access | Times Cited: 50
Therapeutic Potential of Nitazoxanide: An Appropriate Choice for Repurposing versus SARS-CoV-2?
Andrew V. Stachulski, Joshua Taujanskas, Sophie Pate, et al.
ACS Infectious Diseases (2020) Vol. 7, Iss. 6, pp. 1317-1331
Open Access | Times Cited: 46
Discovery of a Novel Chemotype of Histone Lysine Methyltransferase EHMT1/2 (GLP/G9a) Inhibitors: Rational Design, Synthesis, Biological Evaluation, and Co-crystal Structure
Ciro Milite, Alessandra Feoli, J.R. Horton, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 5, pp. 2666-2689
Open Access | Times Cited: 45
1,3-Dipolar Cycloaddition, HPLC Enantioseparation, and Docking Studies of Saccharin/Isoxazole and Saccharin/Isoxazoline Derivatives as Selective Carbonic Anhydrase IX and XII Inhibitors
Melissa D’Ascenzio, Daniela Secci, Simone Carradori, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 5, pp. 2470-2488
Closed Access | Times Cited: 44
Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction–Reconstruction and Fragment-Growing Approach
Giulia Iannelli, Ciro Milite, N. Marechal, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 17, pp. 11574-11606
Open Access | Times Cited: 25
Exploring Arylidene–Indolinone Ligands of Autophagy Proteins LC3B and GABARAP
Alexandria N. Leveille, Thomas Schwarzrock, Hawley Brown, et al.
ACS Medicinal Chemistry Letters (2025) Vol. 16, Iss. 2, pp. 271-277
Open Access
Page 1 - Next Page

Scroll to top